CSPC PharmaHK109301217210931093
Financials
Market Cap
$9.47B5Y beta
0.56EPS (TTM)
$0.0683Free Float
8.37BP/E ratio (TTM)
11.63Revenue (TTM)
$4.34BEBITDA (TTM)
$1.22BPricing
Analyst Ratings
The price target is $1.235 and the stock is covered by 25 analysts.
Buy
22
Hold
2
Sell
1
Information
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.